Leadership & Pay ·
Quest Diagnostics appoints Catherine T. Doherty as EVP with $1.2M equity award
DGXQuest Diagnostics Inc
Quest Diagnostics announced that Catherine T. Doherty will transition to Executive Vice President effective November 1, 2026, overseeing health systems, the joint venture with Corewell Health, and Project Nova. She is scheduled to retire in July 2027. The company approved a $1.2 million restricted stock unit award for her new role, while maintaining her $650,000 base salary and 80% target incentive compensation. Quest Diagnostics operates as a leading diagnostic information services company.